Statins, ECG monitoring and defining myocardial infarction: updates from the European Cardiology Congress
This year’s European Society of Cardiology congress in Munich delivered a mix of new guidelines, trial results and emerging technologies with potential implications for clinical practice.
Among the standout presentations was the Australian STAREE trial, which found statins cut major cardiovascular events by 30% in healthy over-70s — a result likely to influence updates to clinical guidelines.
Here, we take a look at some of the other research that generated a buzz.
New myocardial infarction definition cuts down classification categories